Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Diana Lucia Martinez

ResearcherPublications, citations & collaboration network

Diana Lucia Martinez is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 6 works, 10 citations, an h-index of 3 and an i10-index of 0.

6
Works
10
Citations
3
h-index
0
i10-index

How has Diana Lucia Martinez's publication output changed over time?

ScholarIQpublication output · 2015–2025

Output grew100% over the shown period — from 1 works in 2015 to 2 in 2025.

1
1
2
2
2015201720242025

What are the most-cited papers on Diana Lucia Martinez?

ScholarIQmost cited works
Risk communication in cataract surgery
Diana Lucia Martinez, Iqbal Ike K. Ahmed, Matthew B. Schlenker
BMJ Open Ophthalmology. 20243 CitationsOPEN ACCESS
Virtual follow-up after cataract surgery: systematic review
Angelica Hanna, Diana Lucia Martinez, Marko M. Popovic, Iqbal Ike K. Ahmed, Joshua C. Teichman
Journal of Cataract & Refractive Surgery. 20243 Citations
Socioeconomic status and vision care utilization in Canada: a systematic review
Angelica Hanna, Diana Lucia Martinez, Matthew B. Schlenker, Iqbal Ike K. Ahmed
Canadian Journal of Ophthalmology. 20253 CitationsOPEN ACCESS
Socioeconomic status and visual impairment and ocular disease in Canada
Angelica Hanna, Diana Lucia Martinez, Iqbal Ike K. Ahmed, Matthew B. Schlenker
Canadian Journal of Ophthalmology. 20251 CitationsOPEN ACCESS
Bevacizumab for the treatment of a complicated posterior melanocytoma
Urrets-Zavalia JA, N Crim, E Esposito, L Correa, Gonzalez-Castellanos ME, Diana Lucia Martinez
S4306401280. 20150 CitationsOPEN ACCESS

Related on ScholarIQ

Prism Eye Institute
Institution
Risk communication in cataract surgery
Paper
Virtual follow-up after cataract surgery: systematic review
Paper
Socioeconomic status and vision care utilization in Canada: a systematic review
Paper
Socioeconomic status and visual impairment and ocular disease in Canada
Paper
Bevacizumab for the treatment of a complicated posterior melanocytoma
Paper
470M+ articles · free account